OTCMKTS:HLUYY

H. Lundbeck A/S Stock Forecast, Price & News

$30.19

-0.58 (-1.88 %)

(As of 12/3/2020 12:00 AM ET)

Add

Compare

Today's Range

$29.99

Now: $30.19▼

$30.19

50-Day Range

$28.16

MA: $30.33▼

$32.25

52-Week Range

$25.68

Now: $30.19▼

$44.60

Volume963 shs

Average Volume3,678 shs

Market Capitalization$6.01 billion

P/E Ratio23.59

Dividend Yield1.36%

Beta0.66

H. Lundbeck A/S engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for treating symptomatic neurogenic orthostatic hypotension; Onfi for Lennox-Gastaut syndrome; and Rexulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. H. Lundbeck A/S has research collaboration with Enamine Ltd. The company was founded in 1915 and is headquartered in Valby, Denmark.

Beat the Market (BTM) Rank^™

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for H. Lundbeck A/S.

2.4 Community Rank

Outperform Votes
H. Lundbeck A/S has received 191 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
H. Lundbeck A/S has received 201 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
H. Lundbeck A/S has received 51.28% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about H. Lundbeck A/S and other stocks. Vote “Outperform” if you believe HLUYY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe HLUYY will underperform the S&P 500 over the long term. You may vote once every thirty days.

1.7 Dividend Strength

Dividend Yield
H. Lundbeck A/S has a dividend yield of 1.36%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
H. Lundbeck A/S does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of H. Lundbeck A/S is 14.38%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, H. Lundbeck A/S will have a dividend payout ratio of 21.65% next year. This indicates that H. Lundbeck A/S will be able to sustain or increase its dividend.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, H. Lundbeck A/S insiders have not sold or bought any company stock.

0.6 Earnings and Valuation

Earnings Growth
Earnings for H. Lundbeck A/S are expected to decrease by -25.38% in the coming year, from $2.60 to $1.94 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of H. Lundbeck A/S is 23.59, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.05.
Price to Earnings Ratio vs. Sector
The P/E ratio of H. Lundbeck A/S is 23.59, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.00.
Price to Book Value per Share Ratio
H. Lundbeck A/S has a P/B Ratio of 2.76. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

0.94 out of 5 stars

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Private households

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:HLUYY

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.lundbeck.com

Phone45-3630-1311

Employees5,806

Debt

Debt-to-Equity Ratio0.77

Current Ratio1.10

Quick Ratio0.80

Price-To-Earnings

Trailing P/E Ratio23.59

Forward P/E Ratio11.61

P/E GrowthN/A

Sales & Book Value

Annual Sales$2.55 billion

Price / Sales2.35

Cash Flow$2.84 per share

Price / Cash Flow10.63

Book Value$10.95 per share

Price / Book2.76

Profitability

EPS (Most Recent Fiscal Year)$2.92

Net Income$399.78 million

Net Margins9.83%

Return on Equity26.77%

Return on Assets12.23%

Miscellaneous

Outstanding Shares199,140,000

Market Cap$6.01 billion

Next Earnings Date12/8/2020 (Estimated)

OptionableNot Optionable

$30.19

-0.58 (-1.88 %)

(As of 12/3/2020 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive HLUYY News and Ratings via Email

Sign-up to receive the latest news and ratings for HLUYY and its competitors with MarketBeat's FREE daily newsletter.

H. Lundbeck A/S (OTCMKTS:HLUYY) Frequently Asked Questions

How has H. Lundbeck A/S's stock been impacted by COVID-19 (Coronavirus)?

H. Lundbeck A/S's stock was trading at $31.52 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, HLUYY stock has decreased by 4.2% and is now trading at $30.19.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of H. Lundbeck A/S?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for H. Lundbeck A/S in the last year. There are currently 1 sell rating, 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for H. Lundbeck A/S or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than H. Lundbeck A/S?

Wall Street analysts have given H. Lundbeck A/S a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but H. Lundbeck A/S wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is H. Lundbeck A/S's next earnings date?

H. Lundbeck A/S is scheduled to release its next quarterly earnings announcement on Tuesday, December 8th 2020.
View our earnings forecast for H. Lundbeck A/S.

How were H. Lundbeck A/S's earnings last quarter?

H. Lundbeck A/S (OTCMKTS:HLUYY) issued its quarterly earnings results on Wednesday, November, 4th. The company reported $0.17 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.01 by $0.16. The company earned $547.05 million during the quarter, compared to analysts' expectations of $514.82 million. H. Lundbeck A/S had a net margin of 9.83% and a return on equity of 26.77%.
View H. Lundbeck A/S's earnings history.

Are investors shorting H. Lundbeck A/S?

H. Lundbeck A/S saw a decline in short interest in November. As of November 15th, there was short interest totaling 4,300 shares, a decline of 42.7% from the October 31st total of 7,500 shares. Based on an average trading volume of 15,700 shares, the days-to-cover ratio is presently 0.3 days.
View H. Lundbeck A/S's Short Interest.

Who are some of H. Lundbeck A/S's key competitors?

Some companies that are related to H. Lundbeck A/S include Nomura Research Institute (NRILY), BAE Systems (BAESY), Ocado Group (OCDDY), Sysmex (SSMXY), Techtronic Industries (TTNDY), Compagnie Generale des Etablissements Michelin Societe en commandite par actions (MGDDY), Swire Pacific (SWRAY), Secom (SOMLY), Eisai (ESALY), Shimano (SMNNY), SGS (SGSOY), China CITIC Bank (CHCJY), Ferrovial (FRRVY), UniCredit (UNCFF) and China Mengniu Dairy (CIADY).
View all competitors.

Who are H. Lundbeck A/S's key executives?

H. Lundbeck A/S's management team includes the following people:

Dr. Deborah Dunsire, Pres & CEO (Age 58)
Mr. Anders GÃ¶tzsche, Exec. VP & CFO (Age 53)
Mr. Lars Bang, Exec. VP of Product Devel. & Supply (Age 58)
Mr. Jacob Tolstrup, Exec. VP of Commercial Operations (Age 48)
Dr. Per Johan Luthman, Exec. VP of R&D (Age 61)
Mr. Palle Holm Olesen, Chief Specialist & VP of Investor Relations
Ms. Elise Hauge, Exec. VP and Head of People & Communication (Age 53)
Mr. Ole Chrintz, Sr. VP of International Markets (Age 62)
Mr. Peter Anastasiou, Exec. VP of North America (Age 50)
Mr. Keld Flintholm JÃ¸rgensen, Exec. VP and Head of Corp. Strategy & Bus. Devel. (Age 49)

What is H. Lundbeck A/S's stock symbol?

H. Lundbeck A/S trades on the OTCMKTS under the ticker symbol "HLUYY."

How do I buy shares of H. Lundbeck A/S?

Shares of HLUYY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is H. Lundbeck A/S's stock price today?

One share of HLUYY stock can currently be purchased for approximately $30.19.

How big of a company is H. Lundbeck A/S?

H. Lundbeck A/S has a market capitalization of $6.01 billion and generates $2.55 billion in revenue each year. The company earns $399.78 million in net income (profit) each year or $2.92 on an earnings per share basis. H. Lundbeck A/S employs 5,806 workers across the globe.

What is H. Lundbeck A/S's official website?

The official website for H. Lundbeck A/S is www.lundbeck.com.

How can I contact H. Lundbeck A/S?

H. Lundbeck A/S's mailing address is Ottiliavej 9 Valby, Copenhagen G7, 2500. The company can be reached via phone at 45-3630-1311 or via email at [email protected]

This page was last updated on 12/4/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings